The purpose of the study is to examine if a specific drug called losartan (Cozaar ®),
generally used to treat high blood pressure and to protect kidneys from damage in patients
suffering from Diabetes Mellitus, will have any effect on the nasal inflammation in patients
with cystic fibrosis (CF). The study will be performed at the Pulmonary Division at the
University of Miami, Cincinnati Children's Medical Hospital Center, University of Kansas
Medical Center and University of Alabama-Birmingham.
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami
Collaborators:
Children's Hospital Medical Center, Cincinnati Cystic Fibrosis Foundation University of Alabama at Birmingham University of Kansas Medical Center